EICHORCondition: Bipolar Disorder · Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Efficacy of Aripiprazole in Combination with Lamotrigine in the Long-Term Maintenance Treatment of Bipolar I Disorder in Outpatients with Recent Manic or Mixed Episode
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| University Of Alabama At Birmingham | Birmingham, Alabama, United States | — |
| Southwest Biomedical Research Foundation | Tucson, Arizona, United States | — |
| Pravin Kansagra, M.D. | Anaheim, California, United States | — |
| College Hospital Costa Mesa | Costa Mesa, California, United States | — |
| Pacific Institute For Medical Research, Inc. | Los Angeles, California, United States | — |
| Excell Research | Oceanside, California, United States | — |
| Southern Ca Clinical Research, Inc. | Pasadena, California, United States | — |
| Stanford University | Stanford, California, United States | — |
| Los Angeles Biomedical Research Institute | Torrance, California, United States | — |
| Pacific Clinical Research Medical Group | Upland, California, United States | — |
| Health Sciences America, Llc | Boca Raton, Florida, United States | — |
| Cns Clinical Research Group | Coral Springs, Florida, United States | — |
+ 54 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00277212